(Q44067956)

English

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

scientific article

Statements

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial (English)
Mark E McGovern
Brian R Tulloch
David M Kendall
David Fitz-Patrick
Om P Ganda
Robert S Rosenson
David D Robertson
John P Sheehan
Diabetes Multicenter Research Group
1 July 2002
1568-1576

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit